TTNP   $4.57  -4.79% Market Closed

Titan Pharmaceuticals, Inc.
Total Cash 4.09M
totalCashPerShare 4.476
EBITDA -7.09M
Total Debt 0.00
quickRatio 11.601
currentRatio 12.219
Total Revenue 3.00K
debtToEquity
Revenue/Share 0.004
ROA -1.72632
ROE -3.6898599
grossProfits
freeCashflow -5.21M
operatingCashflow -6.76M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -2376.3333
profitMargins 0.0
enterpriseValue -461.49K
forwardPE
floatShares 700.06K
sharesOutstanding 914.23K
sharesShort 16.97K
sharesShortPriorMonth 19.39K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.45%
heldPercentInstitutions 0.04%
Short Ratio help_outline 1.22%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 4.368
Price To Book help_outline 0.94
earningsQuarterlyGrowth
netIncomeToCommon -5.46M
trailingEps -6.64%
forwardEps -0.91%
enterpriseToEbitda 0.07
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 17
lastUpdated Nov. 7, 2024, 1:53 a.m.